Vaxcyte, Inc.

US$63.89As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PCVXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR 11.70%
Div yield —
ROE (42.68%)
Biotechnology
Beta (5Y) 1.29
PE TTM —
TSR TTM 41.10%
Mkt cap US$10.11B
ROIC (27.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$77
20.74%
(90.51%)
Hold 2|10|10|2|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.69
0.72
0.70
0.74
31.28%
28.60%
12.73%
8.41%
Revenue$M
543.3
571.1
591.8
576.4
6.20%
14.09%
12.57%
11.60%
Peers (US$10.11B)
Cap (US$)
PE
10.23B
—
Capital
TTM
5Y
10Y
Leveragex
0.519
1.551
1.344
EBIT/Intx
1.465
0.202
0.217
Own earn%
65.82
94.09
98.13
Sh yield%
43.73
35.47
40.02
Owners
Insiders/Inst%
5.02
64.83
Short interest%
4.12
SBC / revenue%
2.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
18–23
$1 testx
0.0
Incr. ROIC%
3